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ABSTRACT Limited proteolysis of phage Mu transposase
with three proteases of differing specificities produced a
common pattern of fragmentation. The fragments were
mapped by using a combination of immunoblotting and amino
acid sequence analysis. Our results suggest that the transposase
molecule is organized principally into three domains: an
amino-terminal domain of molecular mass 30 kDa, a core
region of approximately 35 kDa, and a carboxyl-terminal
domain of approximately 10 kDa. The amino-terminal domain
has at least two additional sites that are partially accessible to
proteases. Filter binding and nuclease protection studies were
done to determine the functions of the isolated domains.
Site-specific binding to Mu DNA was localized to the amino-
terminal domain. The core domain showed nonspecific DNA-
binding activity.
Phage Mu transposase is a 75-kDa protein encoded by gene
A (1). Together with the product ofgeneB (2) and several host
proteins, the A protein is exceptionally proficient at trans-
posing Mu DNA into random sites in many bacterial genomes
(3). Proper expression of gene A is absolutely essential for
both replicative and conservative transposition and for Mu
DNA excision. In the absence of gene B, transposition
frequencies are decreased to 1/100th (4) and transposition
events become preferentially intramolecular (5, 6). Mu DNA
excision can be observed in the absence of gene B (7).
Transposition is a multistep process (3). Obligate early
events in transposition include specific recognition of the left
and right ends of Mu DNA (attL and attR). In vitro analysis
of Mu DNA transposition has shown that the A protein is
responsible for the site-specific recognition ofMu DNA ends
(8). Two other proteins, the transposase A ofphage D108 and
the immunity determinant or repressor c of phage Mu, share
DNA-binding sites with Mu A protein. A comparison of the
amino acid sequences of these three proteins has revealed
regions of homology which, at the amino termini of the
proteins, show resemblance to the bihelical DNA-binding
structure found in other site-specific DNA-binding proteins
(1). Besides site-specific DNA binding, transposition also
requires binding to target DNA followed by nicking and
strand-exchange reactions in which three DNA sequences
participate: Mu attL and attR and the host target. The
efficiency of this reaction is increased in the presence of the
Mu B protein.
To understand the mechanism of Mu transposition, we
have begun an analysis of the structure and function of the A
and B proteins. By limited proteolysis of the A protein with
trypsin, chymotrypsin, and Staphylococcus aureus V8 pro-
tease, we show here that the transposase polypeptide is
organized principally into three domains with additional
protease-accessible sites in the amino-terminal domain. Pre-
dictions of hydrophobicity and secondary structure support
the conclusions from our proteolysis experiments. Both
amino-terminal and core domains bind DNA. However, only
the amino-terminal domain shows site-specific binding to Mu
DNA.
MATERIALS AND METHODS
Enzymatic Digestion and Isolation of Fragments. A protein
was purified as described (9). A sample of purified protein
(1.2 mg/ml) in 0.3 M KCl/25 mM Hepes, pH 7.6/0.1 mM
EDTA/1 mM dithiothreitol/10% (vol/vol) glycerol was treat-
ed with trypsin (Sigma catalog no. T 8642), a-chymotrypsin
(Sigma catalog no. C 3142), or S. aureus V8 protease (Sigma
catalog no. P 8400), at a ratio of 3000:1 (wt/wt), and incubated
at 30°C for various times. (Peptides generated by trypsin,
chymotrypsin, and V8 protease are indicated by the prefixes
T-, CT-, and V-, respectively.) Digestion was stopped with
phenylmethanesulfonyl fluoride (added to a final concentra-
tion of 1 mM) and the samples were subjected to electropho-
resis on a NaDodSO4/12.5% polyacrylamide gel (10). Protein
fragments were transferred to nitrocellulose (11) and ana-
lyzed with antibodies specific for three different regions at
the amino terminus of the A protein. These antibodies were
produced by immunization of rabbits with the synthetic
peptides A-(1-22), A-(27-50), and A-(61-88), which represent
fragments of the A-protein sequence deduced in ref. 1. These
peptides were coupled to keyhole limpet hemocyanin (KLH)
with m-maleimidobenzoyl N-hydroxysuccinimide ester as
described (12).
For functional studies, chymotryptic fragments were ap-
plied to a phosphocellulose column equilibrated with 0.1 M
NaCl in HEDG (25 mM Hepes, pH 7.6/0.1 mM EDTA/1 mM
dithiothreitol/10% glycerol) at 4°C. CT30 and CT35 were
eluted with 0.3 M NaCl in HEDG. The eluate was adjusted
to 0.1 M NaCl and applied to a DNA-cellulose column
equilibrated with 0.1 M NaCl in HEDG. CT35 was recovered
in the void volume fractions, while CT30 was eluted with 0.15
M NaCl in HEDG. Recovery of pure fragments was 5-10%.
Bovine serum albumin was added to the final fractions to
prevent loss during concentration and storage. The added
albumin did not interfere with the activity of the purified
fragments. CT28 copurified with CT30. Using immunoblot-
ting, we judged contamination of purified CT30 or CT35 with
native A protein or CT62 to be less than 0.5%.
Protein Sequence Analysis. The Mu A protein was cleaved
with chymotrypsin or S. aureus V8 protease as described
above. Chymotryptic peptides CT62, CT48, CT35, and CT30
were simultaneously purified and prepared for protein se-
quence analysis by the electroblotting method of Aebersold
et al. (13) and then loaded directly into a gas-phase sequena-
tor (14). Peptide CT15 was purified by NaDodSO4/PAGE,
Coomassie blue staining, and electroelution according to the
tTo whom reprint requests should be addressed.
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method of Hunkapiller et al. (15). Peptides V56 and V39 were
purified by NaDodSO4/PAGE, visualizing with 4 M sodium
acetate, and electroelution (15). Peptides purified by electro-
elution were spotted onto quaternary ammonium-modified
glass fiber discs for sequencing (13). The resulting phenyl-
thiohydantoin derivatives were analyzed essentially as de-
scribed by Hunkapiller and Hood (16), except that 5%
(vol/vol) tetrahydrofuran was included in the A buffer, which
was adjusted to pH 5.1.
DNase I Protection Experiments. A 300-base-pair (bp) Alu
I fragment containing Mu attL and flanking host DNA was
cloned in a multiple cloning site vector by using Sal I linkers.
The resulting plasmid pRA-L29 was cut with HindIII and
labeled at the 5' end by using polynucleotide kinase and
[y32P]ATP. After digestion with BamHI, the labeled attL
fragment was purified from a polyacrylamide gel. Approxi-
mately 1-10 nM end-labeled fragment was incubated with
protein in DNase I protection experiments, which were
performed essentially as described (8).
Filter Binding Assay. A 300-bp HindIII-BamHI attL-
containing fragment from pRA-L29 was used as a source of
specific DNA, and a 351-bp Cla I-BamHI fragment from
pBR322 was used as a source of nonspecific DNA. 32p_
labeled DNA fragments (1-10 nM) were incubated in the
assay buffer (25 mM Hepes, pH 7.5/75 mM KCl/1 mM
MgCl2/1 mM dithiothreitol) with various amounts of protein
for 20 min at 37°C. Aliquots were filtered through a presoaked
nitrocellulose filter and washed with assay buffer, and their
radioactivities were measured in a toluene-based scintillant.
RESULTS
Proteolytic Cleavage of Mu A Protein with Chymotrypsin.
Fig. 1A shows the time course of digestion of the 75-kDa Mu
A protein with chymotrypsin. After a 5- or 10-min incubation,
major fragments with masses of62, 48, 35, 30, and 15 kDa are
observed. With prolonged incubation, CT62 and CT48 di-
minish and CT35 accumulates. CT15 and CT35 appear to be
stable. CT30 is also stable, although less so than are CT15 and
CT35. Besides these major products, there are minor species
with masses of 73, 60, 58, 56, 42, 28, 22, and 20 kDa. The
protein fragments were resolved by NaDodSO4/PAGE,
transferred to nitrocellulose, and probed with serum specific
for the peptide A-(27-50) (Fig. 1B). The 75-kDa native A
protein and CT62 and CT30 fragments react with this probe,
and hence the fragments are derived from the amino termi-
nus. Note that all three amino-terminal species appear as
doublets with a molecular mass difference of 2 kDa. The
reason they are equally intense on the immunoblot (Fig. 1B)
but not on the Coomassie blue-stained gel (Fig. 1A) is
saturation of the fragments with antibody. The amino-
terminal-containing chymotryptic doublets were further an-
alyzed by using serum specific for the A-(1-22) peptide (Fig.
1C). Only the larger fragment of each of the three doublets
reacts with this probe, indicating that a chymotrypsin cleav-
age site occurs about 20 residues in from the amino terminus.
When probed with serum specific for the A-(61-88) peptide
(not shown), the minor doublet species CTS8 and CT22 react.
From the pattern of appearance of the chymotryptic frag-
ments, we postulated that CT15 was derived from the
carboxyl terminus and CT35 from the middle of the protein.
These assignments were confirmed by direct sequencing of
the peptide fragments, as seen in Fig. 2. Thus, the stable
products of chymotrypsin digestion are CT30 (amino termi-
nus), CT35 (core), and CT15 (carboxyl terminus).
Proteolytic Cleavage ofMuA Protein with Trypsin. The time
course of digestion with trypsin is shown in Fig. 3A. At early
times the major fragments are T63, T50, T45, T39, T34, T29,
T21, and T10. As digestion continues, T45 diminishes and
T34 accumulates. This behavior parallels that of chymotryp-
sin digestion, in which CT48 diminishes and CT35 accumu-
lates. T70, T63, T50, T39, and T29 are unstable intermedi-
ates. An immunoblot of this digest (Fig. 3B) with serum
specific for the A-(27-50) peptide shows that T63, T29, and
T21 are the amino-terminal fragments. T21 is a stable amino-
terminal species. T63, T34, and T29 thus correspond to CT62,
CT35, and CT30, respectively. T29 is cleaved further to give
T21. We postulate that T10 is derived from the carboxyl
terminus and corresponds to CT15.
Proteolytic Cleavage of Mu A Protein with V8 Protease.
Digestion of Mu A protein with S. aureus V8 protease is
shown in Fig. 3C. Major fragments with masses of 64 and 56
kDa appear first. The 64-kDa fragment disappears as time
progresses, while 39-, 18-, and 12-kDa fragments begin to
accumulate. The 56-kDa fragment appears to be quite stable.
Immunoblot analysis shows that V64 and V12 contain the
amino terminus of the A protein (Fig. 3D). The amino acid
sequences of V56 and V39 are shown in Fig. 2. V39
corresponds to CT35 and T34. V56 is actually a mixture of
two peptides produced by cleavages at two positions, seven
residues apart, near the amino terminus. These cleavages
also result in the production of the V12 fragment(s). We have
not determined whether V12 has a seven-residue ragged end,
as would be predicted from these results. We postulate that
V56 may be further cleaved to produce V18 and V39. The
faint band around 10 kDa may correspond to the carboxyl-
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FIG. 1. NaDodSO4/PAGE and im-
munoblot analysis of Mu transposase chy-
motryptic peptides. At various times 10-,ul
aliquots of the reaction mixture were elec-
trophoresed in polyacrylamide gels, then
either stained with Coomassie blue or blot-
ted onto nitrocellulose and treated with spe-
cific antibodies. Molecular masses are given
in kilodaltons. (A) Coomassie blue staining.
Lanes 1-4, 0-, 10-, 20-, and 40-min digests,
respectively. (B) Immunoblot analysis with
antiserum to peptide fragment A-(27-50) of
Mu A protein. Lanes 1-4 as in A. (C)
Immunoblot analysis of sample from a 10-
min incubation with chymotrypsin. Lanes 1,
treated with antiserum to A-(1-22) peptide;
lane 2, treated with antiserum to A-(27-50)
peptide.
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terminal fragments CT15 and T10. Thus, three proteases with
different, and nonoverlapping, specificities produce similar
patterns of cleavage fragments.
DNA-Binding Activity of Mu A-Protein Fragments. Site-
specific recognition of the left and right ends of Mu DNA is
one of the earliest steps in transposition, a function carried
out by A protein (8). To localize this function to a specific
region of the protein molecule, we carried out preliminary gel
retardation and DNA "footprinting" studies with Mu attL-
and attR-containing DNA fragments and a mixture of CT30
and CT35. The data thus obtained (not shown) suggested that
CT30 bound Mu attL and attR specifically and that CT35
boundDNA nonspecifically. To confirm this observation, the
CT30 and CT35 domains were separated from each other
(Fig. 4A), then their DNA-binding activities were studied in
filter binding assays. Both fragments bound attL-containing
DNA and pBR322 DNA with approximately the same avidity
(Fig. 4B), CT30 having a dissociation constant (Kd) of
approximately 2.3 x 1O-' M and CT35 having a Kd value of
3.3 x 10-7 M. By comparison, native A protein bound DNA
FIG. 2. Protein sequence analysis of transposase pep-
tides generated by limited proteolysis. The regions of the
transposase molecule from which each peptide was de-
rived were determined by alignment of the peptide se-
quences with the published sequence of the native Mu A
protein (1). Numbers correspond to positions in this native
molecule. Homologous sequences are boxed. The symbols
for residues yielding low signals are enclosed by paren-
theses. The standard one-letter symbols are used for
residues; unidentified residues are signified by X. Brack-
eted symbols are tentative assignments arising because
two peptides were sequenced simultaneously and at these
positions each peptide contained the same amino acid.
more efficiently than did either subunit alone, as indicated by
its Kdvalue of 1.0 X 10-7 M.
In a nuclease protection assay, however, only CT30
showed site-specific recognition ofMu DNA ends (Fig. 4C).
The pattern of protection was the same as that observed with
the native A protein. DNA-binding activity of the fragment
varied with the particular preparation. In the experiment in
Fig. 4C, approximately 3- to 5-fold more fragment was
required to achieve the same degree of protection as was
achieved by using the native A protein. The protection
cannot be due to contamination with native protein, which
was less than 0.5%. CT35 failed to protect attL (not shown).
We conclude that the site-specific DNA-binding function of
the A protein resides in the amino-terminal domain.
DISCUSSION
To understand how the complex process of DNA transposi-
tion occurs, we have begun structure/function analyses of
phage Mu transposase, the product of the MuA gene and the
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FIG. 3. NaDodSO4/PAGE and immunoblot analysis ofMu transposase tryptic and V8 peptides. At various times l0-/4 aliquots ofthe reaction
mixture were electrophoresed in polyacrylamide gels, then either stained with Coomassie blue or blotted onto nitrocellulose and treated with
specific antibodies. Molecular masses are given in kilodaltons. (A) Coomassie blue-stained trypsin digest. Lanes 1-4, 0-, 10-, 20-, and 40-mi
digests, respectively. (B) Immunoblot analysis of trypsin digests with antiserum to A-(27-50) peptide. Lanes 1-4 as in A. (C) Coomassie
blue-stained V8 protease digest. Lanes 1-5, 0-, 30-, 60-, 90-, and 120-min digests, respectively. (D) Immunoblot analysis of V8 protease digest
with antiserum to A-(27-50) peptide. Lanes 1-5 as in C.
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FIG. 4. DNA-binding experiments with purified CT30 and CT35. (A) NaDodSO4/PAGE analysis of purified CT30 (lane 1) and CT35 (lane
2). The 68-kDa band in both lanes is bovine serum albumin. Molecular masses of standards (in kDa) are indicated on the left. (B) Nitrocellulose
filter binding ofDNA. 32P-labeled attL-containing DNA fragments (open symbols) or pBR322 DNA fragments (closed symbols) were mixed with
A protein (o), CT30 (c), or CT35 (A&) and passed through nitrocellulose filters. (C) DNase I protection of Mu attL by CT30. Prior to DNase I
digestion, the Mu DNA fragment was incubated with native A protein or CT30. Lanes 1 and 2, A protein at 0.27 and 2.7 AM, respectively; lane
3, no protein; lanes 4 and 5, CT30 at 0.2 and 2.0 AuM, respectively. I, II, and III refer to A-protein binding sites Li, L2, and L3 on attL (8).
The numbers on the left refer to nucleotide positions from the left end of the Mu genome.
primary effector of DNA transposition during the phage life
cycle. The results we have obtained from limited proteolysis
of the A protein, immunoblotting, amino acid sequencing,
and hydrophobicity predictions are summarized in Fig. 5 B,
C, and D and provide the experimental basis for a model of
the organization of structural domains in the A protein (Fig.
5A).
We postulate that the transposase polypeptide is organized
principally into three globular domains (I, II, and III in Fig.
SA) separated by nonglobular, linker regions (open arrows in
Fig. 5A). Domain I has a molecular mass of approximately 30
kDa and, although relatively resistant to proteolysis, contains
two internal sites with partial accessibility to proteases
(closed arrows in Fig. SA). Chymotryptic digestion reveals a
potential cleavage site 20 amino acids from the amino
terminus, suggesting the presence of an oligopeptide "arm"
in this region (wavy line in Fig. SA). Domain II has a
molecular mass of approximately 35 kDa and behaves as a
protease-resistant "core." Domain III has a molecular mass
of approximately 10 kDa and may terminate in an oligopep-
tide arm, as postulated for domain I.
This model is consistent with the data we have presented
here. For example, chyuhotrypsin, trypsin, and V8 protease
can theoretically cleave the transposase polypeptide at any
one of 129 tryptophan, tyrosine, phenylalanine, leucine, or
methionine linkages; 97 lysine or arginine linkages; or 87
glutamic acid linkages, respectively. The fact that only a
small percentage of these sites was actually cleaved and that
each enzyme, although of differing specificity, produced
highly similar families of peptide fragments, demonstrates
that these cleavage sites are clustered in regions accessible to
all three enzymes. The simplest structural corollary for these
regions is a nonglobular interdomain oligopeptide (signified
with open arrows in Fig. SA) connecting globular domains.
Hydrophobicity predictions, done according to Kyte and
Doolittle (17), are consistent with this structure (Fig. 5B).
Especially noteworthy are the occurrence of particularly
hydrophilic oligopeptide regions around residue 572, which
coincides precisely with the cleavage site of fragment CT15
and the predicted sites of cleavage offragments T10 and V10,
and around residues 630 and 655, near the carboxyl terminus
of the polypeptide, where a hydrophilic arm may be located.
Similar very hydrophilic regions near residues 80 and 170
coincide with the cleavage sites of fragments V56 and T21,
respectively. Additionally, a local hydrophobic minimum
occurs near residue 241, which coincides with the interdo-
main cleavage sites of V39, CT35, CT48, and the predicted
site(s) of cleavage of T34 and T45. Such areas of hydrophi-
licity are known to occur in regions of peptide exposed to the
aqueous phase and accessible to enzymes and antibodies
(18).
The existence of an amino-terminal arm in domain I is
suggested by our prediction of an extremely hydrophilic
region near residue 30 at the amino terminus, coinciding with
the cleavage site of fragment CT28, and by analogy to the
phage X repressor, which contains a flexible amino-terminal
arm accessible to proteases (19), and to the trp repressor,
which also contains such an arm (20). Interesting in this
respect is the observation that Chou-Fasman analysis shows
this amino-terminal region to have the highest potential for
,(sheet structure in the whole transposase polypeptide and,
importantly, to contain many sites of potential p-bends
(D.B.T., unpublished data). The presence of such an append-
age is consistent with our finding that domain I functions in
site-specific binding to Mu ends. A flexible or extended
structure could play several special roles in such protein-
DNA interactions. In the case of X repressor, the arm wraps
around the DNA helix, helping to determine sequence
specificity and contributing a large portion of the binding
energy (21).
The core domain shows nonspecific DNA binding. This
domain could function in binding or cleaving the random
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FIG. 5. Domain structure ofMu transposase. The amino terminus
is always to the left. (A) Postulated globular domains (I, II, III) are
separated by, and may contain (I), regions of polypeptide accessible
to proteolytic enzymes. Open arrows signify accessible interdomain
regions. Filled arrows signify accessible intradomain regions. We
postulate that amino- and carboxyl-terminal "arms" (wavy lines)
extend from domains I and III, respectively. (B) Hydrophobicity
prediction was done according to the method of Kyte and Doolittle
(17), using a window of seven residues. The hydrophobicity statistic
(ordinate) was plotted versus the residue number in the A protein
(abscissa). The more positive the statistic the more hydrophobic is
the seven-residue survey region. (C) Proteolytic cleavage map. Sites
of cleavage by chymotrypsin (CT), trypsin (T), and V8 protease (V)
are noted with arrows. Sites with italicized labels are predicted on the
basis of peptide mapping and immunoblot analysis but have not been
confirmed by protein sequence analysis. (D) Major peptide fragments
observed after limited proteolysis. Numbers indicate molecular
masses in kilodaltons. Filled, empty, and hatched rectangles show
sites of binding by antibodies specific for peptides A-(1-22),
A-(27-50), and A-(61-88), respectively. It has not been determined
whether A-(1-22)-specific antibodies bind to T63, T29, T21, or V12.
Asterisks denote peptides whose positions have been confirmed by
protein sequence analysis. The positions of peptides with italicized
labels have been assigned on the basis of peptide map data alone.
target sites into which Mu integrates. We speculate that the
carboxyl-terminal domain of A protein is involved in
protein-protein interactions, especially with the B protein.
We have observed that a deletion of 144 nucleotides from the
3' end of gene A results in a truncated A protein that behaves
as if it were "blind" to the presence of Mu B protein (22).
Several site-specific DNA-binding proteins are organized
into distinct functional domains. Examples include the lac
repressor, X repressor, 434 repressor, cAMP-binding protein,
and y8 resolvase (for a review, see ref. 23). They all have a
bipartite organization, with one domain responsible forDNA
binding and the other for protein-protein interactions. These
proteins are involved in many aspects ofcellular control, with
the exception of y8 resolvase, which in addition catalyzes
DNA strand exchange (24). Mu A protein shares with these
proteins the function of sequence-specific DNA recognition
and DNA strand exchange, but it is different and more
complex in that the strand exchange reactions occur between
three DNA sites and interaction with other proteins is
necessary. The tripartite modular organization of Mu A
protein probably reflects this diversity of required functions.
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